Bekeredjian Raffi, Bodingbauer Dorothea, Hofmann Nina P, Greiner Sebastian, Schuetz Moritz, Geis Nicolas A, Kauczor Hans U, Bryant Mark, Chorianopoulos Emmanuel, Pleger Sven T, Mereles Derliz, Katus Hugo A, Korosoglou Grigorios
University of Heidelberg, Department of Cardiology, Im Neuenheimer Feld 410, Heidelberg, 69120, Germany.
J Invasive Cardiol. 2015 Mar;27(3):172-80.
To investigate if the extent of aortic valve calcification is associated with postprocedural prosthesis eccentricity and paravalvular regurgitation (PAR) in patients undergoing transcatheter aortic valve implantation (TAVI).
Cardiac computed tomography angiography (CCTA) was performed before and 3 months after TAVI in 46 patients who received the self-expanding CoreValve and in 22 patients who underwent balloon-expandable Edwards Sapien XT implantation. Aortic annulus calcification was measured with CCTA prior to TAVI and prosthesis eccentricity was assessed with post-TAVI CCTA. Standard echocardiography was also performed in all patients at 3-month follow-up exam.
Annulus eccentricity was reduced during TAVI using both implantation systems (from 0.23 ± 0.06 to 0.18 ± 0.07 using CoreValve and from 0.20 ± 0.07 to 0.05 ± 0.03 using Edwards Sapien XT; P<.001 for both). With Edwards Sapien XT, eccentricity reduction at the level of the aortic annulus was significantly higher compared with CoreValve (P<.001). Annulus eccentricity after CoreValve use was significantly related to absolute valve calcification and to valve calcification indexed to body surface area (BSA) (r = 0.48 and 0.50, respectively; P<.001 for both). Furthermore, a significant association was observed between aortic valve calcification and PAR (P<.01 by ANOVA) in patients who received CoreValve. Using ROC analysis, a cut-off value over 913 mm² aortic valve calcification predicted the occurrence of moderate or severe PAR with a sensitivity of 92% and a specificity of 63% (area under the curve = 0.75). Furthermore, multivariable analysis showed that aortic valve calcification was a robust predictor of postprocedural eccentricity and PAR, independent of the aortic annulus size and native valve eccentricity and of CoreValve prosthesis size (adjusted r = 0.46 and 0.50, respectively; P<.01 for both). Such associations were not present with the Edwards Sapien XT system.
The extent of native aortic annulus calcification is predictive for postprocedural prosthesis eccentricity and PAR, which is an important marker for long-term mortality in patients undergoing TAVI. This observation applies for the CoreValve, but not for the Edwards Sapien XT valve.
研究经导管主动脉瓣植入术(TAVI)患者的主动脉瓣钙化程度是否与术后人工瓣膜偏心及瓣周反流(PAR)相关。
对46例接受自膨胀CoreValve瓣膜植入术的患者和22例接受球囊扩张式Edwards Sapien XT瓣膜植入术的患者在TAVI术前及术后3个月进行心脏计算机断层扫描血管造影(CCTA)。术前通过CCTA测量主动脉瓣环钙化情况,术后通过CCTA评估人工瓣膜偏心情况。所有患者在3个月随访时还进行了标准超声心动图检查。
使用两种植入系统进行TAVI期间,瓣环偏心均有所降低(使用CoreValve瓣膜时从0.23±0.06降至0.18±0.07,使用Edwards Sapien XT瓣膜时从0.20±0.07降至0.05±0.03;两者P均<0.001)。与CoreValve瓣膜相比,使用Edwards Sapien XT瓣膜时主动脉瓣环水平的偏心降低更为显著(P<0.001)。使用CoreValve瓣膜后瓣环偏心与绝对瓣膜钙化及体表面积(BSA)指数化的瓣膜钙化显著相关(r分别为0.48和0.50;两者P均<0.001)。此外,在接受CoreValve瓣膜植入的患者中,观察到主动脉瓣钙化与PAR之间存在显著关联(方差分析P<0.01)。通过ROC分析,主动脉瓣钙化面积超过913 mm²可预测中度或重度PAR的发生,敏感性为92%,特异性为63%(曲线下面积=0.75)。此外,多变量分析显示,主动脉瓣钙化是术后偏心及PAR的有力预测指标,独立于主动脉瓣环大小、原生瓣膜偏心及CoreValve人工瓣膜大小(调整后r分别为0.46和0.50;两者P均<0.01)。Edwards Sapien XT系统不存在此类关联。
原生主动脉瓣环钙化程度可预测术后人工瓣膜偏心及PAR,而PAR是TAVI患者长期死亡率的重要指标。这一观察结果适用于CoreValve瓣膜,但不适用于Edwards Sapien XT瓣膜。